Accéder au contenu
Merck
  • Foot and ankle kinematics in chronic ankle instability subjects using a midfoot strike pattern when running, including influence of taping.

Foot and ankle kinematics in chronic ankle instability subjects using a midfoot strike pattern when running, including influence of taping.

Clinical biomechanics (Bristol, Avon) (2018-03-05)
Kevin Deschamps, Giovanni Arnoldo Matricali, Bart Dingenen, Jente De Boeck, Sarah Bronselaer, Filip Staes
RÉSUMÉ

Investigate differences in multi-segment foot kinematics between controls and participants with chronic ankle instability during running with a midfoot striking pattern and to evaluate the effect of Low-Dye and High-Dye taping. Three-dimensional multi-segment foot kinematics of 12 controls and 15 participants with chronic ankle instability were collected while running barefoot, and in both taping conditions. Ranges of motion occurring at each joint, each sub phase of stance, were compared between groups and between taping conditions (0-dimensional inference). Kinematic data were also compared using one-dimensional statistical parametric mapping. The symptomatic group demonstrated while barefoot running a significantly decreased rearfoot dorsiflexion range of motion during the peak impact phase as well as a less dorsiflexed position from 6 to 12% of the running cycle. During the absorption and generation phase, the symptomatic group also showed a significantly increased rearfoot dorsiflexion and adduction motion as well as an increased midfoot inversion motion. In the peak impact phase of both taping conditions, a decreased midfoot inversion motion was found. The High-Dye taping resulted in a decreased rearfoot plantarflexion motion whereas the Low-Dye caused a decreased midfoot inversion motion. Persons with chronic ankle instability seem to have altered rearfoot and midfoot kinematics while running with a midfoot striking index. High-Dye taping seems to have better therapeutic features than Low-Dye taping.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Carboxyamidotriazole, ≥98% (HPLC)